Post by Amgen 🧪🔬🧬 on X
Amgen 🧪🔬🧬@Amgen
XHeading into 2026: Amgen bolsters its oncology pipeline.
Amgen will acquire UK-based Dark Blue Therapeutics Ltd. adding an investigational small molecule to treat acute myeloid leukemia (AML).
This builds on our commitment to patients with difficult to treat cancers.
🔗

47 likes3 repliesPosted Jan 6, 2026